Product
Micafungin
5 clinical trials
8 indications
Indication
CandidemiaIndication
Febrile NeutropeniaIndication
Neonatal InfectionIndication
Invasive Fungal InfectionsIndication
CandidiasisIndication
SepsisIndication
MycosisIndication
InvasiveClinical trial
Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins in Patients With Presumptive CandidemiaStatus: Completed, Estimated PCD: 2010-05-01
Clinical trial
Antimicrobial Revision in Patients With Persistent Febrile Neutropenia: A Prospective, Randomized TrialStatus: Recruiting, Estimated PCD: 2025-04-01
Clinical trial
Micafungin Versus Amphotercine B in Treatment of Invasive Fungal Infection In Preterm Neonates: A Randomized Control TrialStatus: Completed, Estimated PCD: 2023-05-20
Clinical trial
A Randomized Comparative Study of Fluconazole Versus Micafungin for the Treatment of Candida Bloodstream Infection in Non-Neutropenic PatientsStatus: Withdrawn, Estimated PCD: 2008-12-01
Clinical trial
Open-Label, Randomized Study to Estimate Safety, PK, and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Standard-of-Care Following IV Echinocandin Therapy in the Treatment of Invasive Candidiasis in Hospitalized Nonneutropenic AdultsStatus: Completed, Estimated PCD: 2016-06-01